This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Norman P. Blair, MD
Chicago, Ill

Arch Ophthalmol. 1989;107(10):1420.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—We appreciate the comments by Drs Lavin and Bird regarding our article. At the time the experiment was planned, we were not aware of the NMDA-receptor blocking action of ketamine. This factor may indeed have contributed to the surprising tolerance of some of our control eyes to ischemia for up to 240 minutes and to the favorable outcome in our vitreoperfusion group. We are currently assessing the role of this receptor in the pathophysiology of ischemic cell injury using our vitreoperfusion technique. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?